nevanac
novartis europharm limited - nepafenaka - pain, postoperative; ophthalmologic surgical procedures - ophthalmologicals - nevanac is indicated for: , prevention and treatment of postoperative pain and inflammation associated with cataract surgery;, reduction in the risk of postoperative macular oedema associated with cataract surgery in diabetic patients.
nevanac 1 mg/1 ml kapi za oko, suspenzija
novartis ba d.o.o. - nepafenak - kapi za oko, suspenzija - 1 mg/1 ml - 1 ml kapi za oko, suspenzije sadrži: 1 mg nepafenaka
ducressa 1 mg/ml + 5 mg/ml kapi za oko, otopina
santen oy, niittyhaankatu 20, tampere, finska - natrijev deksametazonfosfat levofloksacin hemihidrat - kapi za oko, otopina - 1 mg/ml + 5 mg/ml - urbroj: jedan ml otopine sadrži 1 mg deksametazona (u obliku natrijevog deksametazonfosfata) i 5 mg levofloksacina (u obliku levofloksacin hemihidrata)